Edition:
United States

Ocular Therapeutix Inc (OCUL.OQ)

OCUL.OQ on NASDAQ Stock Exchange Global Market

6.17USD
4:00pm EDT
Change (% chg)

$0.12 (+1.98%)
Prev Close
$6.05
Open
$6.16
Day's High
$6.25
Day's Low
$6.04
Volume
75,657
Avg. Vol
84,552
52-wk High
$8.26
52-wk Low
$3.30

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.38 December 16 Aug 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 2 2 2
(2) OUTPERFORM 4 4 3 3
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.80 1.67 1.60 1.60

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 4 0.46 0.50 0.35 0.53
Quarter Ending Dec-18 4 0.43 0.50 0.35 0.53
Year Ending Dec-18 5 1.90 2.00 1.69 4.19
Year Ending Dec-19 5 22.25 30.43 7.13 64.10
Earnings (per share)
Quarter Ending Sep-18 4 -0.38 -0.35 -0.39 -0.46
Quarter Ending Dec-18 4 -0.39 -0.33 -0.44 -0.51
Year Ending Dec-18 5 -1.55 -1.43 -1.70 -1.98
Year Ending Dec-19 5 -1.32 -0.77 -1.73 -0.11

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 0.38 0.65 0.27 72.80
Quarter Ending Mar-18 0.45 0.34 0.11 24.75
Quarter Ending Dec-17 0.52 0.49 0.04 6.95
Quarter Ending Sep-17 0.51 0.52 0.01 2.35
Quarter Ending Jun-17 0.49 0.44 0.05 10.02

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 0.46 0.46 0.40 0.41 0.53
Quarter Ending Dec-18 0.43 0.43 0.40 0.41 0.53
Year Ending Dec-18 1.90 1.90 1.60 1.52 4.19
Year Ending Dec-19 22.25 22.25 24.70 25.87 64.10

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 2 1
Quarter Ending Dec-18 0 0 2 1
Year Ending Dec-18 0 0 3 1
Year Ending Dec-19 0 0 1 1
Earnings